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Nasopharyngeal carcinoma (NPC) is a rare malignancy in most parts of the world but is particularly frequent in China, especially in the South [1] . The average incidence of NPC worldwide is less than 1/100,000 population [2] . However, in endemic areas of China, its incidence reaches 20/100,000 [3] [4] [5] . In the past three decades, NPC incidence has declined among the Chinese residing in Southeast Asia, including Taiwan, Hong Kong, and Singapore [5] -areas with lifestyles distinct from that of mainland China. The National Central Cancer Registry (NCCR) of China, responsible for data collection, evaluation, analysis, and publication from population-based cancer registries, has organized three retrospective mortality surveys on the causes of cancer death, which provide sex-and age-specific mortality for major cancers among areas in mainland China. Recent population-based studies in China show that the incidence of NPC in some areas has remained stable in males and even slightly decreased in females [6, 7] . Additionally, although rates are still higher in persons over 50 years of age, the age-specific mortality in the high risk age group has followed a downward trend over a 30-year period.
The NCCR of China established the Chinese Cancer Registry annual report system to comprehensively promote cancer registration. The Chinese Cancer Registry Annual Report has been published since 2008 and has provided the scientific basis for cancer prevention and control in China. In 2012, the NCCR collected data for the calendar year 2009 from 104 registries. After comprehensive quality evaluation, data from 72 registries were selected as sources of the annual report to reflect cancer incidence and mortality in the registration areas. In this study, NPC cases were retrieved from the national database for analysis to show the updated NPC burden in Chinese population.
Material and Methods
Data source
All new cancer cases diagnosed in 2009 were reported to cancer registries from all hospitals, community health centers, and other institutions, including centers of township medical insurance and the New-type Rural Cooperative Medical System. The death record database was linked and matched with the cancer registration database for identifying cancer deaths and missed cases.
Totally 104 cancer registries (covering 46 cities and 58 counties in 27 provinces) reported cancer registration data to NCCR. The overall population coverage was 109,476,347, accounting for 8.2% of the whole population. The cancer registries coded cancer site and histology according to the International Classification of Diseases for Oncology, third edition (ICD-03) and tenth edition (ICD-10). Invasive cases of NPC (topography code C11) were retrieved and analyzed from the overall cancer database. Demographic information was provided by the National Statistics Bureau.
Quality control
Based on the guideline of Chinese cancer registration [8] and the standard of data inclusion in Cancer Incidence in Five Continents Volume IX [9] , cancer registration data were evaluated by several quality indicators: proportion of morphologic verification (MV%), percentage of cancer cases identified with death certification only (DCO%), and mortality/incidence ratio (M/I) [10] [11] [12] . The detailed standard for data inclusion was shown previously [13] . Generally, data with DCO% less than 20%, an overall MV% more than 55%, and M/I between 0.55 and 0.95 were considered acceptable.
Statistical analysis
Crude incidence and mortality of NPC were prepared by sex, area, and 19 total age groups (<1, 1-4, 5-9,…80-84, ≥ 85 years). Age-standardized rates were calculated using the Chinese population from 1982 and Segi's World population. The cumulative risk of developing or dying from cancer for persons young than 75 years (in the absence of competing causes of death) was calculated and presented as a percentage. Software including MS-FoxPro, MSExcel, and IARCcrgTools issued by the International Agency for Research on Cancer (IARC) and the International Association of Cancer Registration (IACR) were used for data checkup. SAS software (version 9.0) was used to calculate incidence and mortality.
Results
Pooled data
After evaluating all submitted information, data from 72 population-based cancer registries were accepted for the annual report. The population covered by these cancer registries was 85,470,522, including 43,231,554 males and 42,238,968 females, accounting for 6.4% of the whole population. A total of 31 registries were from urban areas, covering a total population of 57,489,009, whereas 41 registries were from rural areas, covering a total population of 27,981,513. The MV%, DCO%, and M/I for the national pooled data were 71.99%, 3.05%, and 0.55, respectively, in urban areas and 70.65%, 3.54%, and 0.56, respectively, in rural areas. There were 3,085 new cases of NPC (2, 197 
Incidence
The crude incidence of NPC was 3.61/100,000 in 2009, accounting for 1.26% of all new cancer cases. The age-standardized incidences by Chinese population (ASIC) and world population (ASIW) were 2.05/100,000 and 2.54/100,000, respectively. Among persons under the age of 75, the cumulative incidence was 0.28%.
NPC occurred more frequently among males than females. For males, the crude incidence of NPC was 5.08/100,000, whereas the ASIC and ASIW were 2.89/100,000 and 3.60/100,000, respectively. For females, the crude incidence of NPC was 2.10/100,000, whereas the ASIC and ASIW were 1.21/100,000 and 1.47/100,000, respectively. The crude incidence in urban areas (4.19/100,000) was higher than that in rural areas (2.42/100,000). After age standardization, incidence in urban areas was still higher than that in rural areas (ASIW, 2.88/100,000 vs. 1.80/100,000; Table 2 ).
Age-specific incidence of NPC for both sexes and areas was compared. Overall, the age-specific incidence was relatively low in persons under 30 years old but dramatically increased in those over 30 years old, peaking in the 60-64 age group in males and urban areas, in 80-84 age group in rural areas, and in 70-74 age group in females. For persons over 30 years old, NPC age-specific incidence was more than 2-fold greater in males than in females, although there were slight differences among those under 30 years old. The agespecific incidence of NPC in urban areas was generally higher than that in rural areas both in males and females, especially in older age groups (Table 3, Figure 1 ).
Mortality
The mortality of NPC was higher in males than in females. The crude mortality, the age-standardized mortalities by Chinese population (ASMC) and world population (ASMW) were 2.82/100,000, 1.51/100,000, and 1.97/100,000, respectively, for males and 1.14/100,000, 0.57/100,000, and 0.74/100,000, respectively, for females. These values were 2.30/100,000, 1.15/100,000, and 1.50/100,000, respectively, in urban areas and 1.37/100,000, 0.78/100,000, and 1.00/100,000, respectively, in rural areas. NPC was confirmed to be a fatal disease in both males and females, and in urban and rural areas (Table 4) .
Age-specific mortality by sex and area is shown in Table 5 and Figure 2 . The mortality was relatively low in age groups under 40 years old and peaked in the over 85 year age group. However, in urban females, the mortality in the 75-79 age group was the highest among all groups and in rural males, the 70-74 age group had the highest mortality of NPC. The age-specific mortality of NPC in urban areas was generally higher than that in rural areas in both males and 
Discussion
For this analysis of NPC incidence and mortality in 2009, 72 registries were qualified as sources of the annual report on cancer burden in 2009. The data in this report covered 85.47 million people (about 57.49 million from 31 urban areas), which is the largest population coverage to date. We analyzed NPC cases including 3,085 newly diagnosed patients and 1,702 deaths-data that might be representative of the whole country.
Compared with other studies in China during past decades, the incidence of NPC has remained stable [14] or slightly decreased [7] in females in low-risk regions, or has slightly increased in males in some high-risk regions [15] . NCCR data analysis revealed that the crude incidence and mortality fluctuated slightly in 2009 due to different population coverage. Additionally, NCCR results showed that incidence was higher in males than in females. The crude incidence in urban areas was also slightly higher than that in rural areas for both males and females. After age standardization, incidences were a 1, urban area; 2, rural area. Chin J Cancer; 2013; Vol. 32 Issue 8 www.cjcsysu.com F i g u r e 1 . A g e -s p e c i f i c incidence of nasopharyngeal carcinoma (NPC) in males and females in urban and rural areas in 2009. The agespecific incidence increased as age increased and peaked in the 60-64 age group in urban males, in the 55-59 age group in rural males, in the 65-69 age group in urban females, and in the 85 and over age group in rural females. Incidences in urban areas were higher than those in rural areas except among females over the age of 75, and incidences in males were higher than those in females in any age group. still higher in males and in urban areas compared to females and rural areas, respectively. The results showed that the age-specific incidence of persons in the 60-64 year old age group in urban areas was 1-2 times higher than that in rural areas, both in males and females.
Although a rare disease worldwide, NPC shows a relatively high incidence among the Chinese, probably because of Epstein-Barr virus (EBV) infection, lifestyle, or smoking-related factors [16] . In endemic areas in China, NPC remains a common and fatal disease. The prevention strategy in China focuses mainly on secondary prevention, with a goal of improving rates of early detection and diagnosis in NPC patients and thereby giving high-risk populations a clinically valuable survival advantage [17] . Since the 1970s, NPC screening tests and studies for high-risk areas in southern China, such as Sihui, have included monitoring for EBV using anti-EBV serum biomarkers [18] [19] [20] [21] [22] , but there is still no confirmed screening scheme for a larger sample [22] in persons in high-risk age ranges [6, 19] , as well as health education and promotion should become standard practice for high-risk areas in China.
In conclusion, although the incidence of NPC remains stable and low in most age groups, especially in the young generation, it is still a major public issue in high-risk regions in China, especially among persons in high-risk age ranges. The cancer registry provides timely and dynamic information for making national, regional, and local policies for cancer control. As NCCR continues to expand the national cancer registry system, primary and secondary prevention of NPC is expected to improve.
